Skip to main content
SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.986
-0.014 (-1.42%)
At close: Apr 28, 2026, 4:00 PM EDT
0.966
-0.020 (-2.00%)
After-hours: Apr 28, 2026, 7:45 PM EDT

SCYNEXIS Revenue

In the year 2025, SCYNEXIS had annual revenue of $20.60M with 449.95% growth. SCYNEXIS had revenue of $18.65M in the quarter ending December 31, 2025, with 1,808.50% growth.

Revenue (ttm)
$20.60M
Revenue Growth
+449.95%
P/S Ratio
3.80
Revenue / Employee
$1,144,500
Employees
18
Market Cap
78.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202520.60M16.86M449.95%
Dec 31, 20243.75M-136.40M-97.33%
Dec 31, 2023140.14M135.05M2,652.72%
Dec 31, 20225.09M-8.07M-61.32%
Dec 31, 202113.16M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Assertio Holdings 118.71M
InterCure 72.16M
Journey Medical 61.86M
Cumberland Pharmaceuticals 44.52M
Alpha Teknova 40.52M
BGM Group 25.10M
Zhengye Biotechnology Holding 21.46M
Talphera 28.00K
Revenue Rankings

SCYX News

More News